14 April 2026, 14:00
EMBL Entrepreneurial Minds - Synchronizing Clocks: From Circadian Biology to Entrepreneurship
14 April 20262026Career EventEMBL Heidelberg, Virtual
Description NOTE THIS TALK WILL TAKE PLACE VIA ZOOM WITH THE OPTION TO ATTEND IN PERSON AT EMBL HAMBURG FOR PEOPLE BASED AT DESYAbstractFrom fundamental discovery at EMBL to founding the circadian medicine startup Timeteller About the speakerProf Dr Angela Rel gio is a systems biologist entrepreneur and internationally recognized expert in circadian biology systems medicine and computational modelling She currently serves as Professor of Systems Medicine at the Medical School Hamburg MSH She has led interdisciplinary research groups investigating how the body s biological clock regulates gene activity cellular processes and disease mechanisms Her research focuses particularly on understanding how circadian rhythms influence disease development and treatment responses especially in cancer biology While leading research groups at Charit Universit tsmedizin Berlin and later at Medical School Hamburg she pioneered work integrating systems biology molecular biology and mathematical modelling to uncover disease driving mechanisms Prof Rel gio holds a joint PhD in Biomedical Sciences Molecular and Cellular Biology from the University of Lisbon and the European Molecular Biology Laboratory EMBL graduating summa cum laude She also holds a diploma in Technological Physics Engineering and postgraduate training in Biophysics and Biomedical Engineering from the University of Lisbon She completed her habilitation in Molecular Biology and Bioinformatics at Charit Universit tsmedizin Berlin in 2016 Her scientific career includes research positions at EMBL Heidelberg and Charit where she later became Research Group Leader for Systems Biology of Cancer and a faculty member of the Berlin School of Integrative Oncology Driven by the insight that the effectiveness and side effects of treatments can strongly depend on biological timing Prof Rel gio translated her scientific discoveries into a diagnostic technology designed to measure an individual s internal clock This work ultimately led to the creation of TimeTeller with the goal of bringing chronomedicine into clinical practice and preventive healthcare Through TimeTeller she aims to bridge the gap between academic research and medical innovation empowering patients and healthcare professionals to use circadian rhythm based insights to improve health outcomes TimeTeller is a spin off from Charit Universit tsmedizin Berlin one of Germany s leading university hospitals and biomedical research institutions The company was founded in Hamburg in 2023 to translate cutting edge research in circadian biology into practical diagnostic tools that enable personalised and time based medicine TimeTeller has three co founders Prof Dr Angela Rel gio Dr Benjamin Dose and the Charit Universit tsmedizin Berlin represented by its technology transfer partner ascension GmbH We ask all participants in person or online to register via zoom https embl org zoom us webinar register WN gB6p0wm1QcS2FHIkkxWBTw registration Please note that the talk will be recorded For the FAQ section as a zoom participant please use the Q A function the host will read out your question... NOTE: THIS TALK WILL TAKE PLACE VIA ZOOM, WITH THE OPTION TO ATTEND IN-PERSON AT EMBL HAMBURG FOR PEOPLE BASED AT DESYAbstractFrom fundamental discovery at EMBL to founding the circadian medicine startup Timeteller. About the speakerProf. Dr. Angela Relógio is a systems biologist, entrepreneur, and internationally recognized expert in circadian biology, systems medicine, and computational modelling.She currently serves as Professor of Systems Medicine at the Medical School Hamburg (MSH). She has led interdisciplinary research groups investigating how the body’s biological clock regulates gene activity, cellular processes, and disease mechanisms.Her research focuses particularly on understanding how circadian rhythms influence disease development and treatment responses, especially in cancer biology. While leading research groups at Charité – Universitätsmedizin Berlin and later at...
Speaker(s): Angela Relógio, CEO & Co-Founder of TimeTeller GmbH, and Professor of Systems Medicine, Medical School Hamburg (MSH), Germany
Host: Laurène Martins and Juergen Bauer, EMBLEM and Aleksandra Bebel, EMBL Fellows' Career Service
Place: Virtual seminar
EMBL Heidelberg, Virtual
Additional information
NOTE: THIS TALK WILL TAKE PLACE VIA ZOOM, WITH THE OPTION TO ATTEND IN-PERSON AT EMBL HAMBURG FOR PEOPLE BASED AT DESY
Abstract
From fundamental discovery at EMBL to founding the circadian medicine startup Timeteller.
About the speaker
Prof. Dr. Angela Relógio is a systems biologist, entrepreneur, and internationally recognized expert in circadian biology, systems medicine, and computational modelling.
She currently serves as Professor of Systems Medicine at the Medical School Hamburg (MSH). She has led interdisciplinary research groups investigating how the body’s biological clock regulates gene activity, cellular processes, and disease mechanisms.
Her research focuses particularly on understanding how circadian rhythms influence disease development and treatment responses, especially in cancer biology. While leading research groups at Charité – Universitätsmedizin Berlin and later at Medical School Hamburg, she pioneered work integrating systems biology, molecular biology, and mathematical modelling to uncover disease-driving mechanisms.
Prof. Relógio holds a joint PhD in Biomedical Sciences (Molecular and Cellular Biology) from the University of Lisbon and the European Molecular Biology Laboratory (EMBL), graduating summa cum laude. She also holds a diploma in Technological-Physics Engineering and postgraduate training in Biophysics and Biomedical Engineering from the University of Lisbon. She completed her habilitation in Molecular Biology and Bioinformatics at Charité – Universitätsmedizin Berlin in 2016.
Her scientific career includes research positions at EMBL Heidelberg and Charité, where she later became Research Group Leader for Systems Biology of Cancer and a faculty member of the Berlin School of Integrative Oncology.
Driven by the insight that the effectiveness and side effects of treatments can strongly depend on biological timing, Prof. Relógio translated her scientific discoveries into a diagnostic technology designed to measure an individual’s internal clock. This work ultimately led to the creation of TimeTeller®, with the goal of bringing chronomedicine into clinical practice and preventive healthcare.
Through TimeTeller, she aims to bridge the gap between academic research and medical innovation, empowering patients and healthcare professionals to use circadian rhythm–based insights to improve health outcomes.
TimeTeller® is a spin-off from Charité – Universitätsmedizin Berlin, one of Germany’s leading university hospitals and biomedical research institutions. The company was founded in Hamburg in 2023 to translate cutting-edge research in circadian biology into practical diagnostic tools that enable personalised and time-based medicine.
TimeTeller has three co-founders: Prof. Dr. Angela Relógio, Dr. Benjamin Dose, and the Charité – Universitätsmedizin Berlin, represented by its technology transfer partner ascension GmbH.
We ask all participants (in-person or online) to register via zoom: https://embl-org.zoom.us/webinar/register/WN_gB6p0wm1QcS2FHIkkxWBTw#/registration
Please note that the talk will be recorded.
*For the FAQ section, as a zoom participant, please use the Q&A function (the host will read out your question).